The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status
Nature Communications - United Kingdom
doi 10.1038/s41467-019-13315-x
Full Text
Open PDFAbstract
Available in full text
Date
November 28, 2019
Authors
Publisher
Springer Science and Business Media LLC